查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
重組細胞培養補充劑市場 - 全球行業規模、份額、趨勢、機會和預測，2018-2028 年，副產品、應用、表達系統、最終用戶、地區、競爭
市場調查報告書
商品編碼
1266842

重組細胞培養補充劑市場 - 全球行業規模、份額、趨勢、機會和預測，2018-2028 年，副產品、應用、表達系統、最終用戶、地區、競爭

Recombinant Cell Culture Supplements Market- Global Industry Size, Share, Trends, Opportunity and Forecast, 2018-2028F, By Product, By Application, By Expression System, By End User, By Region and Competition
出版日期: | 出版商: TechSci Research | 英文 266 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

重組細胞培養補充劑市場在 2022 年價值 4.7276 億美元，由於對生物製劑的需求增加，預計在預測期內將以 8.99% 的複合年增長率進一步增長。

由於細胞培養技術的進步和生物製藥研究投資的增加等因素，預計未來幾年重組細胞培養補充劑市場將繼續增長。

個性化醫療的發展

個性化醫療的發展正在影響重組細胞培養添加劑市場的增長。 個性化醫療根據個別患者的特定需求量身定制治療方案。 這種方法需要開發和生產個性化療法，例如基因和細胞療法。 這些療法需要專門的細胞培養補充劑來優化細胞生長和生產力。

基因組學（對人類基因組的研究）的進步使科學家能夠更好地了解疾病的遺傳基礎。 這些知識導致了靶向治療的發展，這些治療可以根據患者的基因特徵進行定制。 例如，癌症治療現在將針對患者腫瘤中的特定基因突變進行定制，從而帶來更好的結果和更少的副作用。

隨著醫療保健成本持續飆升，人們對更有效和高效的醫療保健的需求不斷增長。 個性化醫療方法提供了更有針對性和更有效治療的潛力，從長遠來看可能會帶來更好的結果並降低醫療成本。 監管環境也可能影響個性化醫療的發展。 近年來，監管機構將重點放在個性化醫療方法的開發和批准上，導致該領域的投資增加。

技術進步也促進了個性化醫療的發展。 新一代測序和 CRISPR 基因編輯等新診斷工具使科學家能夠更好地了解疾病的遺傳基礎並開發靶向療法。 數據分析的進步也使研究人員能夠分析大量基因組和臨床數據，以確定模式並開發新的治療方法。

個性化醫療趨勢正在增長，這推動了對重組細胞培養補充劑的需求。 因此，重組細胞培養補充劑市場有望在未來繼續增長，為市場提供創新和增長的機會。

慢性病患病率上升

慢性病患病率上升正在影響重組細胞培養補充劑市場的增長。 癌症、糖尿病和心血管疾病等慢性病是世界範圍內導致死亡的主要原因，這增加了對治療這些疾病的生物製劑的需求。 由於生物製劑是使用培養的活細胞製造的，因此必須使用重組細胞培養補充劑來優化細胞生長和生產力。 污染、接觸毒素和傳染病等環境因素也可能導致慢性病的發展。 接觸空氣污染與呼吸道和心血管疾病的發展有關，接觸鉛和石棉等有毒物質與癌症的發展有關。 遺傳因素也可以在慢性病的發展中發揮作用，一些疾病具有遺傳成分。 基因檢測和個性化醫療方法可以幫助識別患某些慢性病風險較高的人。

隨著越來越多的患者尋求創新和有效的治療方法，慢性病患病率的上升正在推動重組細胞培養市場的增長。 此外，人口老齡化也有助於該市場的增長。 隨著人們年齡的增長，他們更有可能患上慢性病，從而增加了對創新療法的需求。

隨著慢性病患病率的持續上升，對生物製劑和重組細胞培養補充劑的需求也在增加。 預計這一趨勢將繼續下去，為市場帶來創新和增長的機會。

可自定義

根據市場數據，TechSci Research 根據公司的具體需求提供定制服務。 該報告可以定制為：

公司信息

  • 對其他市場參與者（最多 5 家公司）進行深入分析和概況分析

內容

第 1 章概述

  • 市場定義
  • 市場範圍
    • 目標市場
    • 研究目標年份
    • 主要市場細分

第二章研究方法論

  • 調查目的
  • 基線調查方法
  • 主要行業合作夥伴
  • 主要協會和次要信息
  • 調查方法
  • 數據三角測量和驗證
  • 假設和限制

第 3 章執行摘要

  • 市場概覽
  • 主要市場細分概述
  • 主要市場參與者概覽
  • 主要地區/國家概覽
  • 市場驅動因素、挑戰和趨勢

第 4 章 VOC（客戶之聲）

第 5 章重組細胞培養添加劑的全球市場展望

  • 市場規模和預測
    • 按金額
  • 市場份額和預測
    • 副產品（重組胰島素、重組表皮生長因子、重組白蛋白、重組膠原蛋白、重組轉鐵蛋白、重組胰蛋白□、其他）
    • 按應用（再生醫學與生物生產）
    • 通過再生醫學（幹細胞療法、細胞療法、基因療法）
    • 通過生物生產（單克隆抗體、重組蛋白、激素、疫苗等）
    • 按表達系統（哺乳動物表達系統、大腸桿菌表達系統、酵母表達系統等）
    • 最終用戶（學術/研究機構、生物技術/製藥公司）
    • 按公司分類（2022 年）
    • 按地區
  • 市場地圖
    • 按產品分類
    • 通過申請
    • 通過再生醫學
    • 通過生物生產
    • 通過表達系統
    • 最終用戶
    • 按地區

第 6 章北美重組細胞培養添加劑市場展望

  • 市場規模和預測
    • 按金額
  • 市場份額和預測
    • 按產品分類
    • 通過申請
    • 通過再生醫學
    • 通過生物生產
    • 通過表達系統
    • 最終用戶
    • 按國家
  • 北美：國家/地區分析
    • 美國
    • 墨西哥
    • 加拿大

第 7 章歐洲轉基因細胞培養補充劑市場展望

  • 市場規模和預測
    • 按金額
  • 市場份額和預測
    • 按產品分類
    • 通過申請
    • 通過再生醫學
    • 通過生物生產
    • 通過表達系統
    • 最終用戶
    • 按國家
  • 歐洲：國家分析
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙

第 8 章亞太地區轉基因細胞培養補充劑市場展望

  • 市場規模和預測
    • 按金額
  • 市場份額和預測
    • 按產品分類
    • 通過申請
    • 通過再生醫學
    • 通過生物生產
    • 通過表達系統
    • 最終用戶
    • 按國家
  • 亞太地區：國家/地區分析
    • 中國
    • 日本
    • 韓國
    • 印度
    • 澳大利亞

第 9 章南美重組細胞培養補充劑市場展望

  • 市場規模和預測
    • 按金額
  • 市場份額和預測
    • 按產品分類
    • 通過申請
    • 通過再生醫學
    • 通過生物生產
    • 通過表達系統
    • 最終用戶
    • 按國家
  • 南美洲：：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第 10 章中東和非洲重組細胞培養補充劑市場展望

  • 市場規模和預測
    • 按金額
  • 市場份額和預測
    • 按產品分類
    • 通過申請
    • 通過再生醫學
    • 通過生物生產
    • 通過表達系統
    • 最終用戶
    • 按國家
  • MEA：國家分析
    • 南非重組細胞培養添加劑
    • 沙特阿拉伯重組細胞培養添加劑
    • UAE 重組細胞培養添加劑

第 11 章市場動態

  • 司機
  • 做

第12章市場趨勢與發展

  • 近期發展狀況
  • 併購
  • 產品發布

第 13 章重組細胞培養添加劑的全球市場：SWOT 分析

第 14 章波特的五力分析

  • 行業競爭
  • 新進入的可能性
  • 供應商的力量
  • 客戶力量
  • 替代品的威脅

第15章競爭格局

  • Abcam plc.
  • Corning Incorporated
  • BBI Solutions OEM Limited
  • FUJIFILM Irvine Scientific, Inc.
  • Gemini Bioproducts, LLC
  • HiMedia Laboratories, LLC
  • Kingfisher Biotech, Inc.
  • Lonza Group AG
  • Merck KGaA
  • Novus Biologicals, LLC
  • ThermoFisher Scientific

第 16 章戰略建議

Product Code: 13013

Recombinant Cell Culture Supplements Market was valued at USD 472.76 million in 2022 and is further anticipated to grow at a CAGR of 8.99% during the forecast period, owing to rising demand for biologic drugs. The recombinant cell culture supplements market is expected to continue growing in the coming years, driven by factors such as the advancements in cell culture technologies and rising investment in biopharmaceutical research.

The increasing demand for biologics has been a major driver of the recombinant cell culture supplements market. Biologic drugs are complex molecules that are produced using living cells, which are grown in culture. These drugs are increasingly being used to treat various diseases, such as cancer and autoimmune disorders. As a result, the demand for recombinant cell culture supplements has been on the rise, as they are essential for enhancing cell growth and productivity during the production of biologics.

Advancements in cell culture technologies have also contributed to the growth of the recombinant cell culture supplements market. For instance, single-use bioreactors and perfusion systems have improved cell culture processes by increasing efficiency and reducing costs. These new technologies require specialized cell culture supplements that are optimized for their use, further driving demand for recombinant cell culture supplements.

The rising prevalence of chronic diseases has contributed to the growth of the market. According to the World Health Organization (WHO), chronic diseases such as cancer, diabetes, and cardiovascular diseases are the leading causes of mortality worldwide. Biologic drugs are increasingly being used to treat these diseases, further driving the demand for recombinant cell culture supplements.

The increasing investment in biopharmaceutical research has also contributed to the growth of the market. The pharmaceutical industry is investing heavily in the research and development of new biologic drugs. This investment is driving the demand for recombinant cell culture supplements that can support the development and production of these drugs.

While the recombinant cell culture supplements market is growing rapidly, there are also several challenges that are impeding its growth. The high cost of recombinant cell culture supplements is a major challenge. These supplements are often expensive to produce, which in turn leads to higher prices for customers. This can limit the market potential for these products, particularly in emerging economies where healthcare budgets may be more constrained.

Rising Demand for Biologics Drugs

The demand for biological drugs has been rising due to their effectiveness in treating various diseases. As biological drugs are produced using living cells grown in culture, the demand for recombinant cell culture supplements has also increased. The increasing prevalence of chronic diseases, advancements in cell culture technologies, biosimilar development, and personalized medicine are all contributing to the growth of the biologics drug market, which in turn drives the demand for recombinant cell culture supplements. One of the main factors driving the growing demand for biologics is the increasing prevalence of chronic diseases. Conditions such as cancer, autoimmune disorders, and diabetes are on the rise worldwide, and traditional treatments have not been effective in managing these diseases. Biologics, however, have been shown to be highly effective in treating many of these conditions, leading to an increased demand for these drugs.

Patients are increasingly turning to biological drugs due to their perceived effectiveness and fewer side effects compared to traditional small-molecule drugs. Biologic drugs are also favored by patients who have not responded well to traditional treatments. The regulatory environment can also influence the demand for biological drugs. In recent years, regulatory agencies have placed a greater emphasis on the development and approval of biological drugs, which has increased the availability of these drugs to patients.

The growing demand for biologics has also led to increased investment in research and development. Biotech companies are constantly working to develop new biologics for a wide range of conditions, including rare diseases that previously had no effective treatments. The development of biosimilars, which are similar to existing biological drugs but produced by different manufacturers, has also increased competition and reduced the cost of these drugs. As the demand for biological drugs continues to grow, the recombinant cell culture supplements market is expected to continue to grow as well, providing opportunities for innovation and growth in the industry.

Development of Personalized Medicine

The development of personalized medicine is influencing the growth of the recombinant cell culture supplements market. Personalized medicine involves tailoring treatments to the specific needs of individual patients. This approach requires the development and production of personalized therapeutics, such as gene and cell therapies. These therapies require specialized cell culture supplements, which are used to optimize cell growth and productivity during production.

Advances in genomics, which is the study of the human genome, have enabled scientists to better understand the genetic basis of disease. This knowledge has led to the development of targeted therapies that can be customized to a patient's specific genetic profile. For example, some cancer treatments are now tailored to the specific genetic mutations of a patient's tumor, which can lead to better outcomes and fewer side effects.

As healthcare costs continue to rise, there is a growing demand for more effective and efficient healthcare. Personalized medicine approaches offer the potential for more targeted and effective treatments, which can lead to better outcomes and reduced healthcare costs in the long term. The regulatory environment can also influence the development of personalized medicine. In recent years, regulatory agencies have placed a greater emphasis on the development and approval of personalized medicine approaches, which has led to increased investment in this field.

The development of personalized medicine is also being driven by advances in technology. New diagnostic tools, such as next-generation sequencing and CRISPR gene editing, are allowing scientists to better understand the genetic basis of diseases and develop targeted therapies. In addition, advances in data analytics are enabling researchers to mine large amounts of genomic and clinical data to identify patterns and develop new treatments.

The trend toward personalized medicine is growing, which is driving the demand for recombinant cell culture supplements. As a result, the recombinant cell culture supplements market is expected to continue to grow, providing opportunities for innovation and growth in the market.

Rising Prevalence of Chronic Diseases

The rising prevalence of chronic diseases is influencing the growth of the recombinant cell culture supplements market. Chronic diseases such as cancer, diabetes, and cardiovascular diseases are the leading causes of mortality worldwide, and the demand for biological drugs to treat these diseases is increasing. Biologic drugs are produced using living cells grown in culture, which requires the use of recombinant cell culture supplements to optimize cell growth and productivity. Environmental factors such as pollution, exposure to toxins, and infectious diseases can also contribute to the development of chronic diseases. Exposure to air pollution has been linked to the development of respiratory and cardiovascular diseases, while exposure to toxins such as lead and asbestos has been linked to the development of cancer. Genetic factors can also contribute to the development of chronic diseases, with some conditions having a hereditary component. Genetic testing and personalized medicine approaches can help identify people at higher risk of developing certain chronic diseases.

The rising prevalence of chronic diseases is driving the growth of the recombinant cell culture market as more and more patients seek out innovative and effective treatments. In addition, the aging population is also contributing to the growth of this market. As people age, they are more likely to develop chronic diseases, which has led to an increased demand for new and innovative therapies.

As the prevalence of chronic diseases continues to rise, so does the demand for biological drugs and recombinant cell culture supplements. This trend is expected to continue, providing opportunities for innovation and growth in the market.

Market Segmentation

Global recombinant cell culture supplements market is segmented based on product, application, expression system, end user, and region. Based on product, the market is segmented into Recombinant Insulin, Recombinant Epidermal Growth Factors, Recombinant Albumin, Recombinant Collagen, Recombinant Transferrin, Recombinant Trypsin, and Others. Based on application, the market is further divided into Regenerative Medicine and Bio-Production. Based on regenerative medicine, the market is divided into Stem Cell Therapies, Cell Therapies, and Gene Therapies. Based on bio-production, the market is divided into Monoclonal Antibodies, Recombinant Proteins, Hormones, Vaccines, and Others. Based on the expression system, the market is segmented into Mammalian Expression System, E. coli Expression System, Yeast Expression System, and Others. Based on end users, the market is divided into Biotechnology & Pharmaceutical Companies and Academic & Research Institutions.

Market Players

Abcam plc., Corning Incorporated, BBI Solutions OEM Limited, FUJIFILM Irvine Scientific, Inc., Gemini Bioproducts, LLC, HiMedia Laboratories, LLC, Kingfisher Biotech, Inc., Lonza Group AG, Merck KGaA, Novus Biologicals, LLC, ThermoFisher Scientific, among others, are some of the key players operating in the global Recombinant Cell Culture Supplements Market.

Report Scope:

In this report, Global Recombinant Cell Culture Supplements Market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Recombinant Cell Culture Supplements Market, By Product:

  • Recombinant Insulin
  • Recombinant Epidermal Growth Factors
  • Recombinant Albumin
  • Recombinant Collagen
  • Recombinant Transferrin
  • Recombinant Trypsin
  • Others

Recombinant Cell Culture Supplements Market, By Application:

  • Regenerative Medicine
  • Bio-Production

Recombinant Cell Culture Supplements Market, By Regenerative Medicine:

  • Stem Cell Therapies
  • Cell Therapies
  • Gene Therapies

Recombinant Cell Culture Supplements Market, By Bio-Production:

  • Monoclonal Antibodies
  • Recombinant Proteins
  • Hormones
  • Vaccines
  • Others

Recombinant Cell Culture Supplements Market, By Expression System:

  • Mammalian Expression System
  • E. coli Expression System
  • Yeast Expression System
  • Others

Recombinant Cell Culture Supplements Market, By End User:

  • Biotechnology & Pharmaceutical Companies
  • Academic & Research Institutions

Recombinant Cell Culture Supplements Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Australia
  • South America
    • Brazil
    • Colombia
    • Argentina
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • South Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the global recombinant cell culture supplements market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Recombinant Cell Culture Supplements Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Recombinant Insulin, Recombinant Epidermal Growth Factors, Recombinant Albumin, Recombinant Collagen, Recombinant Transferrin, Recombinant Trypsin, Others)
    • 5.2.2. By Application (Regenerative Medicine v/s Bio-Production)
    • 5.2.3. By Regenerative Medicine (Stem Cell Therapies, Cell Therapies, Gene Therapies)
    • 5.2.4. By Bio-Production (Monoclonal Antibodies, Recombinant Proteins, Hormones, Vaccines, Others)
    • 5.2.5. By Expression System (Mammalian Expression System, E.Coli Expression System, Yeast Expression System, Others)
    • 5.2.6. By End User (Academic & Research Institutions, Biotechnology & Pharmaceutical Companies)
    • 5.2.7. By Company (2022)
    • 5.2.8. By Region
  • 5.3. Market Map
    • 5.3.1. By Product
    • 5.3.2. By Application
    • 5.3.3. By Regenerative Medicine
    • 5.3.4. By Bio-Production
    • 5.3.5. By Expression System
    • 5.3.6. By End User
    • 5.3.7. By Region

6. North America Recombinant Cell Culture Supplements Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Application
    • 6.2.3. By Regenerative Medicine
    • 6.2.4. By Bio-Production
    • 6.2.5. By Expression System
    • 6.2.6. By End User
    • 6.2.7. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Recombinant Cell Culture Supplements Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By Expression System
        • 6.3.1.2.4. By End User
    • 6.3.2. Mexico Recombinant Cell Culture Supplements Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By Expression System
        • 6.3.2.2.4. By End User
    • 6.3.3. Canada Recombinant Cell Culture Supplements Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By Expression System
        • 6.3.3.2.4. By End User

7. Europe Recombinant Cell Culture Supplements Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Application
    • 7.2.3. By Regenerative Medicine
    • 7.2.4. By Bio-Production
    • 7.2.5. By Expression System
    • 7.2.6. By End User
    • 7.2.7. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Recombinant Cell Culture Supplements Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By Expression System
        • 7.3.1.2.4. By End User
    • 7.3.2. United Kingdom Recombinant Cell Culture Supplements Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By Expression System
        • 7.3.2.2.4. By End User
    • 7.3.3. France Recombinant Cell Culture Supplements Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By Expression System
        • 7.3.3.2.4. By End User
    • 7.3.4. Italy Recombinant Cell Culture Supplements Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By Expression System
        • 7.3.4.2.4. By End User
    • 7.3.5. Spain Recombinant Cell Culture Supplements Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By Expression System
        • 7.3.5.2.4. By End User

8. Asia-Pacific Recombinant Cell Culture Supplements Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Application
    • 8.2.3. By Regenerative Medicine
    • 8.2.4. By Bio-Production
    • 8.2.5. By Expression System
    • 8.2.6. By End User
    • 8.2.7. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Recombinant Cell Culture Supplements Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By Expression System
        • 8.3.1.2.4. By End User
    • 8.3.2. Japan Recombinant Cell Culture Supplements Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By Expression System
        • 8.3.2.2.4. By End User
    • 8.3.3. South Korea Recombinant Cell Culture Supplements Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By Expression System
        • 8.3.3.2.4. By End User
    • 8.3.4. India Recombinant Cell Culture Supplements Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By Expression System
        • 8.3.4.2.4. By End User
    • 8.3.5. Australia Recombinant Cell Culture Supplements Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By Expression System
        • 8.3.5.2.4. By End User

9. South America Recombinant Cell Culture Supplements Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Application
    • 9.2.3. By Regenerative Medicine
    • 9.2.4. By Bio-Production
    • 9.2.5. By Expression System
    • 9.2.6. By End User
    • 9.2.7. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Recombinant Cell Culture Supplements Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By Expression System
        • 9.3.1.2.4. By End User
    • 9.3.2. Colombia Recombinant Cell Culture Supplements Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By Expression System
        • 9.3.2.2.4. By End User
    • 9.3.3. Argentina Recombinant Cell Culture Supplements Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By Expression System
        • 9.3.3.2.4. By End User

10. Middle East and Africa Recombinant Cell Culture Supplements Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Application
    • 10.2.3. By Regenerative Medicine
    • 10.2.4. By Bio-Production
    • 10.2.5. By Expression System
    • 10.2.6. By End User
    • 10.2.7. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Recombinant Cell Culture Supplements Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By Expression System
        • 10.3.1.2.4. By End User
    • 10.3.2. Saudi Arabia Recombinant Cell Culture Supplements Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By Expression System
        • 10.3.2.2.4. By End User
    • 10.3.3. UAE Recombinant Cell Culture Supplements Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By Expression System
        • 10.3.3.2.4. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global Recombinant Cell Culture Supplements Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Business Overview
  • 15.2. Product Offerings
  • 15.3. Recent Developments
  • 15.4. Financials (As Reported)
  • 15.5. Key Personnel
  • 15.6. SWOT Analysis
    • 15.6.1. Abcam plc.
    • 15.6.2. Corning Incorporated
    • 15.6.3. BBI Solutions OEM Limited
    • 15.6.4. FUJIFILM Irvine Scientific, Inc.
    • 15.6.5. Gemini Bioproducts, LLC
    • 15.6.6. HiMedia Laboratories, LLC
    • 15.6.7. Kingfisher Biotech, Inc.
    • 15.6.8. Lonza Group AG
    • 15.6.9. Merck KGaA
    • 15.6.10. Novus Biologicals, LLC
    • 15.6.11. ThermoFisher Scientific

16. Strategic Recommendations

List of Figures

  • Figure 1: Global Recombinant Cell Culture Supplements Market Size, By Value (USD Million), 2018-2028F
  • Figure 2: Global Recombinant Cell Culture Supplements Market Share, By Product, By Value, 2018-2028F
  • Figure 3: Global Recombinant Cell Culture Supplements Market Share, By Application, By Value, 2018-2028F
  • Figure 4: Global Recombinant Cell Culture Supplements Market Share, By Application, By Regenerative Medicine, By Value, 2018-2028F
  • Figure 5: Global Recombinant Cell Culture Supplements Market Share, By Application, By Bio-Production, By Value, 2018-2028F
  • Figure 6: Global Recombinant Cell Culture Supplements Market Share, By Expression System, By Value, 2018-2028F
  • Figure 7: Global Recombinant Cell Culture Supplements Market Share, By End User, By Value, 2018-2028F
  • Figure 8: Global Recombinant Cell Culture Supplements Market Share, By Region, By Value, 2018-2028F
  • Figure 9: Global Recombinant Cell Culture Supplements Market Share, By Company, By Value, 2022
  • Figure 10: Global Recombinant Cell Culture Supplements Market Map, By Product, Market Size (USD Million) & Growth Rate (%), 2022
  • Figure 11: Global Recombinant Cell Culture Supplements Market Map, By Application, Market Size (USD Million) & Growth Rate (%), 2022
  • Figure 12: Global Recombinant Cell Culture Supplements Market Map, By Application, By Regenerative Medicine, Market Size (USD Million) & Growth Rate (%), 2022
  • Figure 13: Global Recombinant Cell Culture Supplements Market Map, By Application, By Bio-Production, Market Size (USD Million) & Growth Rate (%), 2022
  • Figure 14: Global Recombinant Cell Culture Supplements Market Map, By Expression System, Market Size (USD Million) & Growth Rate (%), 2022
  • Figure 15: Global Recombinant Cell Culture Supplements Market Map, By End User, Market Size (USD Million) & Growth Rate (%), 2022
  • Figure 16: Global Recombinant Cell Culture Supplements Market Map, By Region, Market Size (USD Million) & Growth Rate (%), 2022
  • Figure 17: North America Recombinant Cell Culture Supplements Market Size, By Value (USD Million), 2018-2028F
  • Figure 18: North America Recombinant Cell Culture Supplements Market Share, By Product, By Value, 2018-2028F
  • Figure 19: North America Recombinant Cell Culture Supplements Market Share, By Application, By Value, 2018-2028F
  • Figure 20: North America Recombinant Cell Culture Supplements Market Share, By Application, By Regenerative Medicine, By Value, 2018-2028F
  • Figure 21: North America Recombinant Cell Culture Supplements Market Share, By Application, By Bio-Production, By Value, 2018-2028F
  • Figure 22: North America Recombinant Cell Culture Supplements Market Share, By Expression System, By Value, 2018-2028F
  • Figure 23: North America Recombinant Cell Culture Supplements Market Share, By End User, By Value, 2018-2028F
  • Figure 24: North America Recombinant Cell Culture Supplements Market Share, By Country, By Value, 2018-2028F
  • Figure 25: United States Recombinant Cell Culture Supplements Market Size, By Value (USD Million), 2018-2028F
  • Figure 26: United States Recombinant Cell Culture Supplements Market Share, By Product, By Value, 2018-2028F
  • Figure 27: United States Recombinant Cell Culture Supplements Market Share, By Application, By Value, 2018-2028F
  • Figure 28: United States Recombinant Cell Culture Supplements Market Share, By Expression System, By Value, 2018-2028
  • Figure 29: United States Recombinant Cell Culture Supplements Market Share, By End User, By Value, 2018-2028F
  • Figure 30: Canada Recombinant Cell Culture Supplements Market Size, By Value (USD Million), 2018-2028F
  • Figure 31: Canada Recombinant Cell Culture Supplements Market Share, By Product, By Value, 2018-2028F
  • Figure 32: Canada Recombinant Cell Culture Supplements Market Share, By Application, By Value, 2018-2028F
  • Figure 33: Canada Recombinant Cell Culture Supplements Market Share, By Expression System, By Value, 2018-2028
  • Figure 34: Canada Recombinant Cell Culture Supplements Market Share, By End User, By Value, 2018-2028F
  • Figure 35: Mexico Recombinant Cell Culture Supplements Market Size, By Value (USD Million), 2018-2028F
  • Figure 36: Mexico Recombinant Cell Culture Supplements Market Share, By Product, By Value, 2018-2028F
  • Figure 37: Mexico Recombinant Cell Culture Supplements Market Share, By Application, By Value, 2018-2028F
  • Figure 38: Mexico Recombinant Cell Culture Supplements Market Share, By Expression System, By Value, 2018-2028
  • Figure 39: Mexico Recombinant Cell Culture Supplements Market Share, By End User, By Value, 2018-2028F
  • Figure 40: Europe Recombinant Cell Culture Supplements Market Size, By Value (USD Million), 2018-2028F
  • Figure 41: Europe Recombinant Cell Culture Supplements Market Share, By Product, By Value, 2018-2028F
  • Figure 42: Europe Recombinant Cell Culture Supplements Market Share, By Application, By Value, 2018-2028F
  • Figure 43: Europe Recombinant Cell Culture Supplements Market Share, By Application, By Regenerative Medicine, By Value, 2018-2028F
  • Figure 44: Europe Recombinant Cell Culture Supplements Market Share, By Application, By Bio-Production, By Value, 2018-2028F
  • Figure 45: Europe Recombinant Cell Culture Supplements Market Share, By Expression System, By Value, 2018-2028F
  • Figure 46: Europe Recombinant Cell Culture Supplements Market Share, By End User, By Value, 2018-2028F
  • Figure 47: Europe Recombinant Cell Culture Supplements Market Share, By Country, By Value, 2018-2028F
  • Figure 48: Germany Recombinant Cell Culture Supplements Market Size, By Value (USD Million), 2018-2028F
  • Figure 49: Germany Recombinant Cell Culture Supplements Market Share, By Product, By Value, 2018-2028F
  • Figure 50: Germany Recombinant Cell Culture Supplements Market Share, By Application, By Value, 2018-2028F
  • Figure 51: Germany Recombinant Cell Culture Supplements Market Share, By Expression System, By Value, 2018-2028
  • Figure 52: Germany Recombinant Cell Culture Supplements Market Share, By End User, By Value, 2018-2028F
  • Figure 53: United Kingdom Recombinant Cell Culture Supplements Market Size, By Value (USD Million), 2018-2028F
  • Figure 54: United Kingdom Recombinant Cell Culture Supplements Market Share, By Product, By Value, 2018-2028F
  • Figure 55: United Kingdom Recombinant Cell Culture Supplements Market Share, By Application, By Value, 2018-2028F
  • Figure 56: United Kingdom Recombinant Cell Culture Supplements Market Share, By Expression System, By Value, 2018-2028
  • Figure 57: United Kingdom Recombinant Cell Culture Supplements Market Share, By End User, By Value, 2018-2028F
  • Figure 58: France Recombinant Cell Culture Supplements Market Size, By Value (USD Million), 2018-2028F
  • Figure 59: France Recombinant Cell Culture Supplements Market Share, By Product, By Value, 2018-2028F
  • Figure 60: France Recombinant Cell Culture Supplements Market Share, By Application, By Value, 2018-2028F
  • Figure 61: France Recombinant Cell Culture Supplements Market Share, By Expression System, By Value, 2018-2028
  • Figure 62: France Recombinant Cell Culture Supplements Market Share, By End User, By Value, 2018-2028F
  • Figure 63: Italy Recombinant Cell Culture Supplements Market Size, By Value (USD Million), 2018-2028F
  • Figure 64: Italy Recombinant Cell Culture Supplements Market Share, By Product, By Value, 2018-2028F
  • Figure 65: Italy Recombinant Cell Culture Supplements Market Share, By Application, By Value, 2018-2028F
  • Figure 66: Italy Recombinant Cell Culture Supplements Market Share, By Expression System, By Value, 2018-2028
  • Figure 67: Italy Recombinant Cell Culture Supplements Market Share, By End User, By Value, 2018-2028F
  • Figure 68: Spain Recombinant Cell Culture Supplements Market Size, By Value (USD Million), 2018-2028F
  • Figure 69: Spain Recombinant Cell Culture Supplements Market Share, By Product, By Value, 2018-2028F
  • Figure 70: Spain Recombinant Cell Culture Supplements Market Share, By Application, By Value, 2018-2028F
  • Figure 71: Spain Recombinant Cell Culture Supplements Market Share, By Expression System, By Value, 2018-2028
  • Figure 72: Spain Recombinant Cell Culture Supplements Market Share, By End User, By Value, 2018-2028F
  • Figure 73: Asia Pacific Recombinant Cell Culture Supplements Market Size, By Value (USD Million), 2018-2028F
  • Figure 74: Asia Pacific Recombinant Cell Culture Supplements Market Share, By Product, By Value, 2018-2028F
  • Figure 75: Asia Pacific Recombinant Cell Culture Supplements Market Share, By Application, By Value, 2018-2028F
  • Figure 76: Asia Pacific Recombinant Cell Culture Supplements Market Share, By Application, By Regenerative Medicine, By Value, 2018-2028F
  • Figure 77: Asia Pacific Recombinant Cell Culture Supplements Market Share, By Application, By Bio-Production, By Value, 2018-2028F
  • Figure 78: Asia Pacific Recombinant Cell Culture Supplements Market Share, By Expression System, By Value, 2018-2028F
  • Figure 79: Asia Pacific Recombinant Cell Culture Supplements Market Share, By End User, By Value, 2018-2028F
  • Figure 80: Asia Pacific Recombinant Cell Culture Supplements Market Share, By Country, By Value, 2018-2028F
  • Figure 81: China Recombinant Cell Culture Supplements Market Size, By Value (USD Million), 2018-2028F
  • Figure 82: China Recombinant Cell Culture Supplements Market Share, By Product, By Value, 2018-2028F
  • Figure 83: China Recombinant Cell Culture Supplements Market Share, By Application, By Value, 2018-2028F
  • Figure 84: China Recombinant Cell Culture Supplements Market Share, By Expression System, By Value, 2018-2028
  • Figure 85: China Recombinant Cell Culture Supplements Market Share, By End User, By Value, 2018-2028F
  • Figure 86: Japan Recombinant Cell Culture Supplements Market Size, By Value (USD Million), 2018-2028F
  • Figure 87: Japan Recombinant Cell Culture Supplements Market Share, By Product, By Value, 2018-2028F
  • Figure 88: Japan Recombinant Cell Culture Supplements Market Share, By Application, By Value, 2018-2028F
  • Figure 89: Japan Recombinant Cell Culture Supplements Market Share, By Expression System, By Value, 2018-2028
  • Figure 90: Japan Recombinant Cell Culture Supplements Market Share, By End User, By Value, 2018-2028F
  • Figure 91: South Korea Recombinant Cell Culture Supplements Market Size, By Value (USD Million), 2018-2028F
  • Figure 92: South Korea Recombinant Cell Culture Supplements Market Share, By Product, By Value, 2018-2028F
  • Figure 93: South Korea Recombinant Cell Culture Supplements Market Share, By Application, By Value, 2018-2028F
  • Figure 94: South Korea Recombinant Cell Culture Supplements Market Share, By Expression System, By Value, 2018-2028
  • Figure 95: South Korea Recombinant Cell Culture Supplements Market Share, By End User, By Value, 2018-2028F
  • Figure 96: India Recombinant Cell Culture Supplements Market Size, By Value (USD Million), 2018-2028F
  • Figure 97: India Recombinant Cell Culture Supplements Market Share, By Product, By Value, 2018-2028F
  • Figure 98: India Recombinant Cell Culture Supplements Market Share, By Application, By Value, 2018-2028F
  • Figure 99: India Recombinant Cell Culture Supplements Market Share, By Expression System, By Value, 2018-2028
  • Figure 100: India Recombinant Cell Culture Supplements Market Share, By End User, By Value, 2018-2028F
  • Figure 101: Australia Recombinant Cell Culture Supplements Market Size, By Value (USD Million), 2018-2028F
  • Figure 102: Australia Recombinant Cell Culture Supplements Market Share, By Product, By Value, 2018-2028F
  • Figure 103: Australia Recombinant Cell Culture Supplements Market Share, By Application, By Value, 2018-2028F
  • Figure 104: Australia Recombinant Cell Culture Supplements Market Share, By Expression System, By Value, 2018-2028
  • Figure 105: Australia Recombinant Cell Culture Supplements Market Share, By End User, By Value, 2018-2028F
  • Figure 106: South America Recombinant Cell Culture Supplements Market Size, By Value (USD Million), 2018-2028F
  • Figure 107: South America Recombinant Cell Culture Supplements Market Share, By Product, By Value, 2018-2028F
  • Figure 108: South America Recombinant Cell Culture Supplements Market Share, By Application, By Value, 2018-2028F
  • Figure 109: South America Recombinant Cell Culture Supplements Market Share, By Application, By Regenerative Medicine, By Value, 2018-2028F
  • Figure 110: South America Recombinant Cell Culture Supplements Market Share, By Application, By Bio-Production, By Value, 2018-2028F
  • Figure 111: South America Recombinant Cell Culture Supplements Market Share, By Expression System, By Value, 2018-2028F
  • Figure 112: South America Recombinant Cell Culture Supplements Market Share, By End User, By Value, 2018-2028F
  • Figure 113: South America Recombinant Cell Culture Supplements Market Share, By Country, By Value, 2018-2028F
  • Figure 114: Brazil Recombinant Cell Culture Supplements Market Size, By Value (USD Million), 2018-2028F
  • Figure 115: Brazil Recombinant Cell Culture Supplements Market Share, By Product, By Value, 2018-2028F
  • Figure 116: Brazil Recombinant Cell Culture Supplements Market Share, By Application, By Value, 2018-2028F
  • Figure 117: Brazil Recombinant Cell Culture Supplements Market Share, By Expression System, By Value, 2018-2028
  • Figure 118: Brazil Recombinant Cell Culture Supplements Market Share, By End User, By Value, 2018-2028F
  • Figure 119: Colombia Recombinant Cell Culture Supplements Market Size, By Value (USD Million), 2018-2028F
  • Figure 120: Colombia Recombinant Cell Culture Supplements Market Share, By Product, By Value, 2018-2028F
  • Figure 121: Colombia Recombinant Cell Culture Supplements Market Share, By Application, By Value, 2018-2028F
  • Figure 122: Colombia Recombinant Cell Culture Supplements Market Share, By Expression System, By Value, 2018-2028
  • Figure 123: Colombia Recombinant Cell Culture Supplements Market Share, By End User, By Value, 2018-2028F
  • Figure 124: Argentina Recombinant Cell Culture Supplements Market Size, By Value (USD Million), 2018-2028F
  • Figure 125: Argentina Recombinant Cell Culture Supplements Market Share, By Product, By Value, 2018-2028F
  • Figure 126: Argentina Recombinant Cell Culture Supplements Market Share, By Application, By Value, 2018-2028F
  • Figure 127: Argentina Recombinant Cell Culture Supplements Market Share, By Expression System, By Value, 2018-2028
  • Figure 128: Argentina Recombinant Cell Culture Supplements Market Share, By End User, By Value, 2018-2028F
  • Figure 129: Middle East & Africa Recombinant Cell Culture Supplements Market Size, By Value (USD Million), 2018-2028F
  • Figure 130: Middle East & Africa Recombinant Cell Culture Supplements Market Share, By Product, By Value, 2018-2028F
  • Figure 131: Middle East & Africa Recombinant Cell Culture Supplements Market Share, By Application, By Value, 2018-2028F
  • Figure 132: Middle East & Africa Recombinant Cell Culture Supplements Market Share, By Application, By Regenerative Medicine, By Value, 2018-2028F
  • Figure 133: Middle East & Africa Recombinant Cell Culture Supplements Market Share, By Application, By Bio-Production, By Value, 2018-2028F
  • Figure 134: Middle East & Africa Recombinant Cell Culture Supplements Market Share, By Expression System, By Value, 2018-2028F
  • Figure 135: Middle East & Africa Recombinant Cell Culture Supplements Market Share, By End User, By Value, 2018-2028F
  • Figure 136: Middle East & Africa Recombinant Cell Culture Supplements Market Share, By Country, By Value, 2018-2028F
  • Figure 137: UAE Recombinant Cell Culture Supplements Market Size, By Value (USD Million), 2018-2028F
  • Figure 138: UAE Recombinant Cell Culture Supplements Market Share, By Product, By Value, 2018-2028F
  • Figure 139: UAE Recombinant Cell Culture Supplements Market Share, By Application, By Value, 2018-2028F
  • Figure 140: UAE Recombinant Cell Culture Supplements Market Share, By Expression System, By Value, 2018-2028
  • Figure 141: UAE Recombinant Cell Culture Supplements Market Share, By End User, By Value, 2018-2028F
  • Figure 142: Saudi Arabia Recombinant Cell Culture Supplements Market Size, By Value (USD Million), 2018-2028F
  • Figure 143: Saudi Arabia Recombinant Cell Culture Supplements Market Share, By Product, By Value, 2018-2028F
  • Figure 144: Saudi Arabia Recombinant Cell Culture Supplements Market Share, By Application, By Value, 2018-2028F
  • Figure 145: Saudi Arabia Recombinant Cell Culture Supplements Market Share, By Expression System, By Value, 2018-2028
  • Figure 146: Saudi Arabia Recombinant Cell Culture Supplements Market Share, By End User, By Value, 2018-2028F
  • Figure 147: South Africa Recombinant Cell Culture Supplements Market Size, By Value (USD Million), 2018-2028F
  • Figure 148: South Africa Recombinant Cell Culture Supplements Market Share, By Product, By Value, 2018-2028F
  • Figure 149: South Africa Recombinant Cell Culture Supplements Market Share, By Application, By Value, 2018-2028F
  • Figure 150: South Africa Recombinant Cell Culture Supplements Market Share, By Expression System, By Value, 2018-2028
  • Figure 151: South Africa Recombinant Cell Culture Supplements Market Share, By End User, By Value, 2018-202